Company: SMNR
Filing Date: 2025-08-13
Form Type: 424B3
Source: 0001193125-25-179226
Chunk: 583

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-13
Form: 424B3
Chunk 583
---
 will terminate if not exercised (if applicable) at or prior to the effective time of the corporate transaction, and any reacquisition or repurchase rights held by Semnur with respect to such awards will lapse (contingent upon the effectiveness of the corporate transaction). The New Semnur Board may elect to adopt severance and change in control agreements in the future if it determines that doing so is in the best interests of New Semnur. Perquisites, Health, Welfare and Retirement Benefits Semnur does not provide perquisites or personal benefits to its executive officers. The New Semnur Board may elect to adopt qualified or nonqualified benefit plans in the future if it determines that doing so is in the best interests of New Semnur. Pension Benefits and Nonqualified Deferred Compensation Semnur does not provide a pension plan or nonqualified deferred compensation plan for its executive officers. The New Semnur Board may elect to adopt a pension plan or nonqualified deferred compensation plan for its executive officers in the future if it determines that doing so is in the best interests of New Semnur. Outstanding Equity Awards at Fiscal Year-End 2024 The following table presents certain information concerning outstanding equity awards held by each of Scilex’s named executive officers as of December 31, 2024.

|                 |     | Option Awards(1)(2) |           |     |              |           |     |             |   |     |               |            |     |           |      |     |            |           |
|                 |     | Option Grant Date   |           |     | Vesting      
 Commencement 
 Date         |           |     | Number of   
 Securities  
 Underlying  
 Unexercised 
 Options (#) 
 Exercisable |   |     | Number of     
 Securities    
 Underlying    
 Unexercised   
 Options (#)   
 Unexercisable |            |     | Option    
 Exercise  
 Price ($) |      |     | Option     
 Expiration 
 Date       |           |
| Jaisim Shah     |     |                     | 8/30/2024 |     |              | 8/30/2024 |     |             | — |     |               | 17,500,000 |     |           | 1.58 |     |            | 8/30/2034 |
| Henry Ji, Ph.D. |     |                     | 8/30/2024 |     |              | 8/30/2024 |     |